Lukas Bubendorf
Impact in
- Oncology top 0.2%
- Cancer Immunotherapy and Biomarkers
- HER2/EGFR in Cancer Research
- Cancer Research top 0.5%
- Cancer Genomics and Diagnostics
Papers in
-
- Lung Cancer Treatments and Mutations 87
- Prostate Cancer Treatment and Research 50
- Lung Cancer Diagnosis and Treatment 33
- Prostate Cancer Diagnosis and Treatment 32
-
- Cancer Genomics and Diagnostics 55
- Co-authors
- Guido Sauter (38 shared papers)Michael Jörg Mihatsch (34 shared papers)Juha Kononen (18 shared papers)Peter Schraml (11 shared papers)Thomas Christian Gasser (41 shared papers)Holger Moch (20 shared papers)Joachim K. H. Torhorst (3 shared papers)Maarit Tuulikki Barlund (2 shared papers)
- Journals
- Journal of Thoracic Oncology (30 papers)Lung Cancer (19 papers)Cancer Cytopathology (13 papers)The Journal of Pathology (13 papers)Annals of Oncology (12 papers)
- Partner nations
- SwitzerlandUnited StatesGermany
In The Last Decade
Lukas Bubendorf
374 papers receiving 23.4k citations
Lukas Bubendorf's Hit Papers
Peers
Comparison fields: 5 of 159
- Oncology 7.6k
- Cancer Research 4.1k
- Pulmonary and Respiratory Medicine 8.3k
- Molecular Biology 8.4k
- Radiology, Nuclear Medicine and Imaging 1.7k
Countries citing papers authored by Lukas Bubendorf
This map shows the geographic impact of Lukas Bubendorf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lukas Bubendorf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lukas Bubendorf more than expected).
Fields of papers citing papers by Lukas Bubendorf
This network shows the impact of papers produced by Lukas Bubendorf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lukas Bubendorf. The network helps show where Lukas Bubendorf may publish in the future.
Co-authors
The 25 scholars most cited alongside Lukas Bubendorf, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 392 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Tissue microarrays for high-throughput molecular profiling of tumor specimens Hit paper breakdown → | 1998 | 3511 |
| 2 | Metastatic patterns of prostate cancer: An autopsy study of 1,589 patients Hit paper breakdown → | 2000 | 1460 |
| 3 | PD-L1 Immunohistochemistry Comparability Study in Real-Life Clinical Samples: Results of Blueprint Phase 2 Project Hit paper breakdown → | 2018 | 648 |
| 4 | Survey of gene amplifications during prostate cancer progression by high-throughout fluorescence in situ hybridization on tissue microarrays. | 1999 | 507 |
| 5 | 2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up Hit paper breakdown → | 2014 | 414 |
| 6 | Tissue microarrays for gene amplification surveys in many different tumor types. | 1999 | 391 |
| 7 | A Grading System for Invasive Pulmonary Adenocarcinoma: A Proposal From the International Association for the Study of Lung Cancer Pathology Committee Hit paper breakdown → | 2020 | 384 |
| 8 | 2001 | 338 | |
| 9 | IASLC Multidisciplinary Recommendations for Pathologic Assessment of Lung Cancer Resection Specimens After Neoadjuvant Therapy Hit paper breakdown → | 2020 | 331 |
| 10 | 2006 | 327 | |
| 11 | 1999 | 326 | |
| 12 | Loss of NKX3.1 expression in human prostate cancers correlates with tumor progression. | 2000 | 311 |
| 13 | 1999 | 305 | |
| 14 | 2001 | 275 | |
| 15 | 2018 | 255 | |
| 16 | 2019 | 255 | |
| 17 | 2001 | 252 | |
| 18 | 2014 | 248 | |
| 19 | 2000 | 247 | |
| 20 | 2020 | 220 |
About Lukas Bubendorf
Lukas Bubendorf is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research, Oncology, Surgery and Molecular Biology, having authored 392 papers that have together received 24.1k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (87 papers), Cancer Genomics and Diagnostics (55 papers), Prostate Cancer Treatment and Research (50 papers), Bladder and Urothelial Cancer Treatments (49 papers), Lung Cancer Diagnosis and Treatment (33 papers), Prostate Cancer Diagnosis and Treatment (32 papers), Lung Cancer Research Studies (26 papers) and Urinary and Genital Oncology Studies (26 papers). The work is most often cited by research in Oncology (7.6k citations), Cancer Research (4.1k citations), Pulmonary and Respiratory Medicine (8.3k citations), Molecular Biology (8.4k citations) and Radiology, Nuclear Medicine and Imaging (1.7k citations). Lukas Bubendorf has collaborated with scholars based in Switzerland, United States and Germany. Frequent co-authors include Guido Sauter, Michael Jörg Mihatsch, Juha Kononen, Peter Schraml, Thomas Christian Gasser, Holger Moch, Joachim K. H. Torhorst, Maarit Tuulikki Barlund, Stephen B. Leighton and Niels Willi. Their work appears in journals such as Journal of Thoracic Oncology, Lung Cancer, Cancer Cytopathology, The Journal of Pathology and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.